Qs which track are in negative territory. The big weight, one of the big weights is netflix. Down 25 in the past month. Its one of those stocks that move on no news, they move because they move. Today investors are paying a price. Sheila dharmarajan is at the nasdaq and is down the composite is down 3. 2 . Sheila . Ugly day here at the nasdaq. The composite and the 100 down by more than 2 . We just bounced off the session lows but keep in mind we are on track for one of the worst days we have seen at the nasdaq in two months. Heres whats amazing. This is a really broadbased selloff, not just biotechs or momentum names. It is weakness across the board here. If you take a look at the nasdaq 100, more than 90 of its members are in the red right now. So everyone is pushing the sell button on seemingly everything. Some particular pockets of weakness, though, got to talk about the biotech names. This is one of the groups that led the nasdaq up. Now today, the nasdaq biotech index is down by
That initially sent stocks higher, even pushing the dow and the s p to record high levels. But then investors began to sell socalled momentum stocks, companies that had been some of the sharpest and fastest price gains over the past year. Big Name Technology giants, biotech companies, internet and social networking darlings, all of them suffering from big drops. The dow fell triple digits down 160 points. But the nasdaq was the hardest hit, losing 110 points. Thats a drop of more than 2. 5 . And the s p lost almost 24 points. Sheila dharmarajan watched the market drama from the Nasdaq Exchange and explains whats worrying investors. Reporter the selloff was broadbased as 97 of the nasdaq 100 finished the day in the red. Amongst the big losers, biotech stocks. The big run up we have seen in those names losing favor this year. The nasdaq biotech index was down more than 4 on the day. Also highflying socalled momentum stocks, these are stocks that consistently move in a directionmetimes re
Higher, even pushing the dow and the s p to record high levels. But then investors began to sell socalled momentum stocks, companies that had been some of the sharpest and fastest price gains over the past year. Big Name Technology giants, biotech companies, internet and social networking darlings, all of them suffering from big drops. The dow fell triple digits down 160 points. But the nasdaq was the hardest hit, losing 110 points. Thats a drop of more than 2. 5 . And the s p lost almost 24 points. Sheila dharmarajan watched the market drama from the Nasdaq Exchange and explains whats worrying investors. Reporter the selloff was broadbased as 97 of the nasdaq 100 finished the day in the red. Amongst the big losers, biotech stocks. The big run up we have seen in those names losing favor this year. The nasdaq biotech index was down more than 4 on the day. Also highflying socalled momentum stocks, these are stocks that consistently move in a directionmetimes regardless oe moment up switc
That initially sent stocks higher, even pushing the dow and the s p to record high levels. But then investors began to sell socalled momentum stocks, companies that had been some of the sharpest and fastest price gains over the past year. Big Name Technology giants, biotech companies, internet and social networking darlings, all of them suffering from big drops. The dow fell triple digits down 160 points. But the nasdaq was the hardest hit, losing 110 points. Thats a drop of more than 2. 5 . And the s p lost almost 24 points. Sheila dharmarajan watched the market drama from the Nasdaq Exchange and explains whats worrying investors. Reporter the selloff was broadbased as 97 of the nasdaq 100 finished the day in the red. Amongst the big losers, biotech stocks. The big run up we have seen in those names losing favor this year. The nasdaq biotech index was down more than 4 on the day. Also highflying socalled momentum stocks, these are stocks that consistently move in a directionmetimes re